Apollomics chair holds 41.8% stake, adds $2M note
Rhea-AI Filing Summary
Apollomics Inc. received additional funding support from its chairman and CEO, Hung‑Wen (Howard) Chen, who, together with his wholly owned entity King Regent Management Limited, beneficially owns 901,362 Class A ordinary shares, representing 41.8% of the class.
On March 30, 2026, the company issued a $2,000,000 Convertible Promissory Note to Mr. Chen as an unsecured bridge loan. The principal will automatically convert into Apollomics equity in the next equity financing that raises at least $10,000,000, at a conversion price equal to 80% of the lowest per‑share purchase price in that financing. If no such financing occurs by the eighteen‑month maturity, Mr. Chen may elect to convert the note into Class A ordinary shares based on the average closing price over the ten trading days before maturity.
Mr. Chen holds 138,334 Class A ordinary shares directly, and King Regent holds 763,028 shares. In addition, on March 15, 2026, 5,000 restricted stock units granted to Mr. Chen vested, each representing the right to receive one Class A ordinary share.
Positive
- None.
Negative
- None.
Insights
Filing highlights concentrated insider ownership and a new $2M insider bridge loan.
This Schedule 13D/A shows that Hung‑Wen Chen and his wholly owned vehicle King Regent Management Limited beneficially own 901,362 Class A ordinary shares of Apollomics Inc., or 41.8% of the class. That level of ownership implies significant influence over shareholder decisions.
The filing also describes a $2,000,000 unsecured Convertible Promissory Note that Apollomics issued to Mr. Chen on March 30, 2026 as a bridge loan. The note automatically converts into equity if the company completes a “Next Equity Financing” raising at least $10,000,000, at a conversion price equal to 80% of the lowest per‑share price in that financing.
If no qualifying financing occurs by the eighteen‑month maturity, Mr. Chen can elect to convert based on the average closing price over the ten trading days before maturity. The filing also notes vesting of 5,000 restricted stock units on March 15, 2026, modestly increasing Mr. Chen’s equity exposure. Overall, the update is structurally important but does not by itself establish a clearly positive or negative financial impact.
Key Figures
Key Terms
Convertible Promissory Note financial
bridge loan financial
Next Equity Financing financial
restricted stock units financial
beneficially owned financial
Percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much of Apollomics Inc. (APLM) does Hung-Wen Chen beneficially own?
What are the key terms of the $2,000,000 convertible note Apollomics issued to Hung-Wen Chen?
When can Hung-Wen Chen choose to convert the Apollomics note if no equity financing occurs?
What recent equity awards to Hung-Wen Chen are disclosed for Apollomics (APLM)?
What triggers the automatic conversion of the Apollomics note called the Next Equity Financing?
AI-generated analysis. How Rhea-AI works. Not financial advice.